Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

The cream effectively reduces excessive hair growth and related skin issues without side effects.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Hirsutism greatly lowers the quality of life for Turkish women.

Diane 35 plus finasteride is more effective for treating hirsutism.

Flutamide reduces hair growth better but has more side effects.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Finasteride reduces hair growth and is safe for women with excessive hair.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Spironolactone plus finasteride works better for treating hirsutism.

Finasteride and metformin both help treat PCOS, but using them together works best.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.